BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Trofinetide readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Trofinetide\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07730112-10752@assetmemo.bio
DTSTAMP:20261121T004040Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:Trofinetide: Phase na readout est. (NCT07730112)
DESCRIPTION:Trofinetide\, phase na\, Rett Syndrome.\nStudy: Adapting a Psyc
 hosocial Support Intervention for the Rett Syndrome Community\nEstimated p
 rimary completion: 31 May 2028. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/trofinetide#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07730112
URL:https://assetmemo.bio/drug/trofinetide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
